BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15894174)

  • 1. Heat treatment decreases melanin synthesis via protein phosphatase 2A inactivation.
    Kim DS; Park SH; Kwon SB; Youn SW; Park ES; Park KC
    Cell Signal; 2005 Aug; 17(8):1023-31. PubMed ID: 15894174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation.
    Kim DS; Hwang ES; Lee JE; Kim SY; Kwon SB; Park KC
    J Cell Sci; 2003 May; 116(Pt 9):1699-706. PubMed ID: 12665551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terrein: a new melanogenesis inhibitor and its mechanism.
    Park SH; Kim DS; Kim WG; Ryoo IJ; Lee DH; Huh CH; Youn SW; Yoo ID; Park KC
    Cell Mol Life Sci; 2004 Nov; 61(22):2878-85. PubMed ID: 15558216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes.
    Kim DS; Kim SY; Chung JH; Kim KH; Eun HC; Park KC
    Cell Signal; 2002 Sep; 14(9):779-85. PubMed ID: 12034359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of heat on the UVB-induced tyrosinase activation and melanogenesis via ERK/p38/MITF pathway in human epidermal melanocytes.
    Gu WJ; Ma HJ; Zhao G; Yuan XY; Zhang P; Liu W; Ma LJ; Lei XB
    Arch Dermatol Res; 2014 Aug; 306(6):583-90. PubMed ID: 24671267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
    Kim DS; Park SH; Park KC
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin-induced Akt activation decreases melanogenesis through downregulation of microphthalmia-associated transcription factor and tyrosinase.
    Jeong HS; Gu GE; Jo AR; Bang JS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Eur J Pharmacol; 2015 Aug; 761():19-27. PubMed ID: 25934572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVS-1357 inhibits melanogenesis via prolonged ERK activation.
    Kim DS; Lee HK; Park SH; Chae CH; Park KC
    Pharmazie; 2009 Aug; 64(8):532-7. PubMed ID: 19746843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menadione (Vitamin K3) decreases melanin synthesis through ERK activation in Mel-Ab cells.
    Kim EH; Kim MK; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Eur J Pharmacol; 2013 Oct; 718(1-3):299-304. PubMed ID: 24012927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of heat and p38 MAPK inhibitor treatment on melanin synthesis.
    Kim DS; Park SH; Kwon SB; Na JI; Huh CH; Park KC
    Arch Pharm Res; 2007 May; 30(5):581-6. PubMed ID: 17615677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geranylgeranylacetone inhibits melanin synthesis via ERK activation in Mel-Ab cells.
    Kim EH; Jeong HS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Life Sci; 2013 Aug; 93(5-6):226-32. PubMed ID: 23792203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes.
    Kim DS; Park SH; Kwon SB; Park ES; Huh CH; Youn SW; Park KC
    Pigment Cell Res; 2006 Apr; 19(2):146-53. PubMed ID: 16524430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein inhibits melanogenesis through activation of the ERK signaling pathway.
    Li X; Guo L; Sun Y; Zhou J; Gu Y; Li Y
    Int J Mol Med; 2010 Jun; 25(6):923-7. PubMed ID: 20428797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways.
    Shin JS; Cho JH; Lee H; Jeong HS; Kim MK; Yun HY; Kwon NS; Kim DS
    Biomed Pharmacother; 2017 Aug; 92():122-127. PubMed ID: 28535415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Melanogenic Activities of Heracleum moellendorffii via ERK1/2-Mediated MITF Downregulation.
    Alam MB; Seo BJ; Zhao P; Lee SH
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopigmentary action of dihydropyranocoumarin D2, a decursin derivative, as a MITF-degrading agent.
    Kim DS; Park SH; Lee HK; Choo SJ; Lee JH; Song GY; Yoo ID; Kwon SB; Na JI; Park KC
    J Nat Prod; 2010 May; 73(5):797-800. PubMed ID: 20392068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of N,N,N-trimethyl phytosphingosine-iodide on melanogenesis via ERK activation-mediated MITF degradation.
    Lee WJ; Bang S; Chung BY; Jung H; Oh ES; Chang SE
    Biosci Biotechnol Biochem; 2016; 80(1):121-7. PubMed ID: 26263195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation.
    Son YO; Lee SA; Kim SS; Jang YS; Chun JC; Lee JC
    J Pharm Pharmacol; 2011 Oct; 63(10):1309-19. PubMed ID: 21899547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
    Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
    J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfanyl peptide decreases melanin synthesis via receptor-mediated ERK activation and the subsequent downregulation of MITF and tyrosinase.
    Choi HR; Kang YA; Lee HS; Park KC
    Int J Cosmet Sci; 2016 Jun; 38(3):279-85. PubMed ID: 26518989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.